logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10220087 B1

PDFFull Text
Date of Patent:
Mar. 05, 2019

Filed:

Apr. 27, 2017

Optimized hiv envelope gene and expression thereof

Applicant:

International Aids Vaccine Initiative, New York, NY (US);

Inventors:

Christopher L. Parks, New York, NY (US);

Maoli Yuan, New York, NY (US);

Xinsheng Zhang, New York, NY (US);

Aaron Wilson, New York, NY (US);

Angela Grazia Lombardo, New York, NY (US);

Eddy Sayeed, New York, NY (US);

Josephine Helena Cox, New York, NY (US);

Takashi Hironaka, Ibaraki, JP;

Makoto Inoue, Ibaraki, JP;

Hiroto Hara, Ibaraki, JP;

Assignee:

INTERNATIONAL AIDS VACCINE INITIATIVE, New York, NY (US);

Attorneys:

Duane Morris LLP

Thomas J. Kowalski

Deborah L. Lu

Primary Examiner:

Barry A Chestnut

Int. Cl.
CPC ...
A61K 39/21 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01); C12N 15/63 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/57 (2013.01); A61K 2039/575 (2013.01); A61K 2039/70 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16234 (2013.01); C12N 2740/16271 (2013.01); C12N 2740/16334 (2013.01); C12N 2760/18443 (2013.01); C12N 2760/18843 (2013.01); C12N 2760/18871 (2013.01); C12N 2760/20243 (2013.01);
Abstract

The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.

Find Patent Forward Citations

Parks, Christopher. (2019). Optimized hiv envelope gene and expression thereof (U.S. Patent No. 10220087). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10220087

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…